0001628280-25-039731.txt : 20250811 0001628280-25-039731.hdr.sgml : 20250811 20250811210050 ACCESSION NUMBER: 0001628280-25-039731 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250807 FILED AS OF DATE: 20250811 DATE AS OF CHANGE: 20250811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARABE TIMOTHY C CENTRAL INDEX KEY: 0001237409 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42790 FILM NUMBER: 251203692 MAIL ADDRESS: STREET 1: C/O ARQULE, INC. STREET 2: 1 WALL STREET, 6TH FLOOR CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Heartflow, Inc. CENTRAL INDEX KEY: 0001464521 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 260506743 STATE OF INCORPORATION: DE FISCAL YEAR END: 0811 BUSINESS ADDRESS: STREET 1: 331 E EVELYN AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 BUSINESS PHONE: 650-241-1221 MAIL ADDRESS: STREET 1: 331 E EVELYN AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 FORMER COMPANY: FORMER CONFORMED NAME: Cardiovascular Simulation, Inc. DATE OF NAME CHANGE: 20090519 4 1 wk-form4_1754960446.xml FORM 4 X0508 4 2025-08-07 0 0001464521 Heartflow, Inc. HTFL 0001237409 BARABE TIMOTHY C C/O HEARTFLOW, INC. 331 E. EVELYN AVENUE MOUNTAIN VIEW CA 94041 1 0 0 0 0 Common Stock 2025-08-11 4 C 0 131578 A 168357 D Stock Option 19 2025-08-07 4 A 0 23710 0 A 2035-08-07 Common Stock 23710 23710 D Convertible Promissory Note 15.20 2025-08-11 4 C 0 131578 0 D Common Stock 131578 0 D Upon the closing of Heartflow, Inc.'s ("Heartflow") initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis. The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date. /s/ Angela Ahmad, Attorney-in-Fact for Timothy C. Barabe 2025-08-11